WealthShield Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
WealthShield Partners's PFE Position: Q2 2026 in Review
WealthShield Partners sold out of Pfizer (PFE) in Q2 2026, closing a stake of 29,174 shares — an estimated $819K sold.
WealthShield Partners first reported a position in PFE in Q3 2020 and held it in 23 quarters. The position peaked at $1.4M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- WealthShield Partners reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- WealthShield Partners sold 29,174 Pfizer shares in Q2 2026, an estimated $819K.
- WealthShield Partners first reported a position in Pfizer in Q3 2020 and held it in 23 quarters.
- WealthShield Partners's Pfizer position peaked at $1.4M in Q4 2021.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.